Table 5.
Summary of Significant Regression Line Positive Slopes by Cancer, Substance and P-Value Calculations Utilize Logarithm of Rates of Cannabis and Cannabinoid Exposure
| No | Cancer | Cigarettes | AUD | Analgesics | Cocaine | Cannabis | THC | Cannabidiol | Cannabichromene | Cannabinol | Cannabigerol |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Prostate | 4.68E-19 | 6.73E-26 | 4.86E-04 | 1.15E-44 | ||||||
| 2 | Ovary | 2.50E-14 | 3.40E-16 | 1.52E-04 | 2.53E-09 | 7.61E-36 | |||||
| 3 | Bladder | 4.78E-05 | 2.65E-14 | 1.66E-06 | 1.27E-11 | 2.77E-29 | 1.70E-10 | 2.02E-05 | |||
| 4 | Colorectal | 1.60E-95 | 1.50E-14 | 4.96E-23 | |||||||
| 5 | All_Cancer | 6.10E-30 | 2.48E-02 | 1.69E-19 | |||||||
| 6 | Hodgkins | 1.08E-02 | 1.87E-06 | 3.37E-02 | 2.20E-12 | ||||||
| 7 | Lung | 5.75E-119 | 1.15E-03 | 1.31E-10 | |||||||
| 8 | Brain | 1.84E-05 | 1.04E-08 | ||||||||
| 9 | NH_Lymphoma | 2.25E-04 | 1.05E-08 | ||||||||
| 10 | Esophagus | 2.75E-02 | 8.06E-05 | 3.68E-08 | |||||||
| 11 | Stomach | 2.43E-12 | 3.05E-04 | ||||||||
| 12 | Breast | 2.09E-07 | 1.07E-15 | 1.09E-11 | 3.03E-03 | 1.68E-14 | 7.57E-11 | 1.94E-14 | |||
| 13 | Liver | 2.15E-27 | 9.68E-54 | 3.08E-28 | 4.67E-56 | 7.57E-40 | |||||
| 14 | Thyroid | 9.25E-30 | 1.16E-52 | 1.29E-31 | 3.86E-52 | 6.51E-37 | |||||
| 15 | Pancreas | 5.58E-09 | 1.60E-22 | 2.03E-09 | 1.54E-23 | 1.49E-15 | |||||
| 16 | AML | 2.22E-07 | 4.73E-22 | 3.32E-08 | 8.47E-24 | 3.05E-12 | |||||
| 17 | Oropharynx | 4.82E-05 | 1.14E-08 | 5.82E-10 | 4.08E-04 | ||||||
| 18 | Kidney | 6.19E-09 | 2.84E-05 | 3.38E-06 | |||||||
| 19 | Melanoma | 4.15E-03 | 3.47E-03 | 2.14E-03 | 1.91E-02 | ||||||
| 20 | Cervix | 5.88E-38 | 2.41E-06 | ||||||||
| 21 | Vulva.&.Vagina | 6.79E-18 | |||||||||
| 22 | Penis | 6.90E-06 | |||||||||
| 23 | Kaposi | 8.98E-04 | |||||||||
| 24 | CLL | 1.78E-06 | |||||||||
| Cancer Numbers | 14 | 9 | 3 | 8 | 6 | 8 | 12 | 6 | 8 | 8 |